These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30736708)

  • 1. The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetes.
    Lage MJ; Boye KS; Bae JP; Wu J; Mody R; Botros FT
    J Med Econ; 2019 May; 22(5):447-454. PubMed ID: 30736708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic burden of comorbid chronic kidney disease and diabetes.
    McQueen RB; Farahbakhshian S; Bell KF; Nair KV; Saseen JJ
    J Med Econ; 2017 Jun; 20(6):585-591. PubMed ID: 28128669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of progressive chronic kidney disease among patients with type 2 diabetes.
    Vupputuri S; Kimes TM; Calloway MO; Christian JB; Bruhn D; Martin AA; Nichols GA
    J Diabetes Complications; 2014; 28(1):10-6. PubMed ID: 24211091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical costs associated with chronic kidney disease progression in an Asian population with type 2 diabetes mellitus.
    Low S; Lim SC; Zhang X; Wang J; Yeo SJD; Yeoh LY; Liu YL; Subramaniam T; Sum CF
    Nephrology (Carlton); 2019 May; 24(5):534-541. PubMed ID: 30141833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
    Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
    J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
    [No Abstract]   [Full Text] [Related]  

  • 7. Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
    Nichols GA; Ustyugova A; Déruaz-Luyet A; O'Keeffe-Rosetti M; Brodovicz KG
    J Am Soc Nephrol; 2020 Jul; 31(7):1594-1601. PubMed ID: 32487562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes and Healthcare Resource Utilization in a Real-World Population Reflecting the DAPA-CKD Trial Participants.
    Olufade T; Lamerato L; Sánchez JJG; Jiang L; Huang J; Nolan S; Rangaswami J
    Adv Ther; 2021 Feb; 38(2):1352-1363. PubMed ID: 33474707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes associated with concordance of oral antidiabetic drug treatments to prescribing information in patients with type 2 diabetes mellitus and chronic kidney disease.
    Chen SY; Lee YC; Alas V; Greene M; Brixner D
    J Med Econ; 2013; 16(5):586-95. PubMed ID: 23402560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes.
    Rossing P; Groehl F; Mernagh P; Folkerts K; Garreta-Rufas A; Harris J; Meredith K; Carter M; Åkerborg Ö; Wanner C; Hobbs FDR
    J Med Econ; 2023; 26(1):935-943. PubMed ID: 37439218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual deterioration of renal function in hypertensive patients with and without diabetes.
    Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
    Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and healthcare use of patients with chronic kidney disease in the Northern Territory, Australia.
    Chen W; Howard K; Gorham G; Abeyaratne A; Zhao Y; Adegboye O; Kangaharan N; Talukder MRR; Taylor S; Cass A;
    BMC Health Serv Res; 2024 Jul; 24(1):791. PubMed ID: 38982437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective.
    Laliberté F; Bookhart BK; Vekeman F; Corral M; Duh MS; Bailey RA; Piech CT; Lefebvre P
    J Manag Care Pharm; 2009 May; 15(4):312-22. PubMed ID: 19422271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of chronic kidney disease using estimated glomerular filtration rate among diabetes patients attending a tertiary clinic in Botswana.
    Rwegerera GM; Molefe-Baikai OJ; Masaka A; Shimwela M; Rivera YP; Oyewo TA; Godman BB; Massele A; Habte D
    Hosp Pract (1995); 2018 Oct; 46(4):214-220. PubMed ID: 30058409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Cardiovascular Disease and Chronic Kidney Disease on Life Expectancy and Direct Medical Cost in a 10-Year Diabetes Cohort Study.
    Wan EYF; Chin WY; Yu EYT; Wong ICK; Chan EWY; Li SX; Cheung NKL; Wang Y; Lam CLK
    Diabetes Care; 2020 Aug; 43(8):1750-1758. PubMed ID: 32457057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic kidney disease on A1C in individuals being screened for diabetes.
    Shipman KE; Jawad M; Sullivan KM; Ford C; Gama R
    Prim Care Diabetes; 2015 Apr; 9(2):142-6. PubMed ID: 24893965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study.
    Pasea L; Dashtban A; Mizani M; Bhuva A; Morris T; Mamza JB; Banerjee A
    Open Heart; 2023 Sep; 10(2):. PubMed ID: 37758654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synergistic effect of variability in estimated glomerular filtration rate with chronic kidney disease on all-cause mortality prediction in patients with type 2 diabetes: a retrospective cohort study.
    Chang YS; Li YH; Lee IT
    Cardiovasc Diabetol; 2021 Oct; 20(1):209. PubMed ID: 34663321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.